Allstate (NYSE: ALL) insider filing details CEO stock sales and options

Rhea-AI Filing Summary

The Allstate Corporation’s chairman, president and CEO Thomas J. Wilson reported open-market sales of Allstate common stock and related option movements. On December 15, 2025, he sold Allstate shares in several transactions at weighted-average prices of $208.3456, $209.3955, $210.3659 and $210.9611 per share under a Rule 10b5-1 trading plan adopted on June 27, 2025.

After these sales, he directly owned 128,005.491 Allstate shares, with additional indirect holdings through multiple GRATs, a 401(k) plan and trusts. The filing also lists employee stock options with exercise prices of $122.64, $137.10 and $159.17 per share, some of which were transferred on December 12, 2025 to TJW Options LLC series entities, while other option tranches remain directly held and vest in increments through 2027.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WILSON THOMAS J

(Last) (First) (Middle)

C/O THE ALLSTATE CORPORATION

3100 SANDERS ROAD

(Street)

NORTHBROOK IL 60062-7154

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALLSTATE CORP [ ALL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman, President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/15/2025		S		1,444	D	$208.3456(1)	143,368.491(2)	D
Common Stock	12/15/2025		S		3,810	D	$209.3955(3)	139,558.491(2)	D
Common Stock	12/15/2025		S		9,545	D	$210.3659(4)	130,013.491(2)	D
Common Stock	12/15/2025		S		2,008	D	$210.9611(5)	128,005.491(2)	D
Common Stock								111,442	I	By 2023-B GRAT
Common Stock								65,321	I	By 2024-C GRAT
Common Stock								69,822	I	By 2025-A GRAT
Common Stock								7,679	I	By 401(k) Plan
Common Stock								273,954	I	By 2020 GRAT Remainder Trust
Common Stock								257,535	I	Remainder GRAT

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$122.64							02/17/2025	02/17/2032	Common Stock	0		0(6)	D
Employee Stock Option (Right to Buy)	$122.64							02/17/2025	02/17/2032	Common Stock	68,215		68,215	I	By TJW Options LLC 2022 Series First Third
Employee Stock Option (Right to Buy)	$122.64							02/17/2025	02/17/2032	Common Stock	68,216		68,216	I	By TJW Options LLC 2022 Series Middle Third
Employee Stock Option (Right to Buy)	$122.64							02/17/2025	02/17/2032	Common Stock	68,216		68,216(6)	I	By TJW Options LLC 2022 Series Last Third
Employee Stock Option (Right to Buy)	$137.1							(7)	02/16/2033	Common Stock	52,612		52,612(8)	D
Employee Stock Option (Right to Buy)	$137.1							(7)	02/16/2033	Common Stock	52,611		52,611	I	By TJW Options LLC 2023 Series First Third
Employee Stock Option (Right to Buy)	$137.1							(7)	02/16/2033	Common Stock	52,612		52,612(8)	I	By TJW Options LLC 2023 Series Middle Third
Employee Stock Option (Right to Buy)	$159.17							(9)	02/21/2034	Common Stock	79,856		79,856(10)	D
Employee Stock Option (Right to Buy)	$159.17							(9)	02/21/2034	Common Stock	39,928		39,928(10)	I	By TJW Options LLC 2024 Series First Third

Explanation of Responses:

1. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $207.725 to $208.690. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

2. The sale transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on June 27, 2025.

3. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $208.825 to $209.780. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

4. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $209.835 to $210.8275. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

5. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $210.840 to $211.145. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

6. Reflects transfer of 68,216 vested employee options to TJW Options LLC 2022 Series Last Third on December 12, 2025, formerly held directly by the reporting person.

7. Stock option award granted on February 16, 2023 for 157,835 shares of common stock exercisable in three increments. The remaining increment will vest on February 16, 2026.

8. Reflects transfer of 52,612 vested employee options to TJW Options LLC 2023 Series Middle Third on December 12, 2025, formerly held directly by the reporting person. 52,612 unvested employee options remain directly held.

9. Stock option award granted on February 21, 2024, for 119,784 shares of common stock vesting in three equal increments. The remaining increments will vest on February 21, 2026 and February 21, 2027.

10. Reflects transfer of 39,928 vested employee options to TJW Options LLC 2024 Series First Third on December 12, 2025, formerly held directly by the reporting person. 79,856 unvested employee options remain directly held.

	/s/ Thomas J. Wilson	12/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider stock transactions did Allstate (ALL) disclose in this filing?

The filing shows that chairman, president and CEO Thomas J. Wilson sold Allstate common stock on December 15, 2025 in four open-market transactions at weighted-average prices of $208.3456, $209.3955, $210.3659 and $210.9611 per share. The sales were reported as code S, indicating open-market or private sales.

How many Allstate (ALL) shares does the CEO own after the reported transactions?

Following the reported sales, Thomas J. Wilson directly owned 128,005.491 shares of Allstate common stock. He also reported indirect ownership of 111,442 shares via a 2023-B GRAT, 65,321 via a 2024-C GRAT, 69,822 via a 2025-A GRAT, 7,679 through a 401(k) plan, 273,954 via a 2020 GRAT Remainder Trust and 257,535 via a Remainder GRAT.

Were the Allstate (ALL) CEO’s stock sales made under a Rule 10b5-1 trading plan?

Yes. The explanation notes that the sale transactions reported were effected pursuant to a Rule 10b5-1 trading plan that was adopted on June 27, 2025. The filing also allows investors and SEC staff to request detailed information about the number of shares sold at each separate price within the reported price ranges.

What stock option holdings are reported for the Allstate (ALL) CEO?

The filing lists several employee stock options (rights to buy). These include options with an exercise price of $122.64 expiring on February 17, 2032, options with an exercise price of $137.10 expiring on February 16, 2033, and options with an exercise price of $159.17 expiring on February 21, 2034, each covering Allstate common stock in specified amounts. Some awards vest in increments, with remaining vesting dates on February 16, 2026, February 21, 2026 and February 21, 2027.

What transfers of stock options to LLCs are described for Allstate (ALL)’s CEO?

The explanations state that 68,216 vested employee options were transferred on December 12, 2025 to TJW Options LLC 2022 Series Last Third, 52,612 vested options were transferred to TJW Options LLC 2023 Series Middle Third and 39,928 vested options were transferred to TJW Options LLC 2024 Series First Third, all formerly held directly by the reporting person. Certain unvested options remain directly held.